To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
EstratestEstratest is hormone replacement therapy drug that combines esterified estrogens with methyltestosterone in one pill. Additional recommended knowledge
IndicationsEstratest is used to treat menopausal women who suffer from hot flashes but do not get relief from estrogen-only therapy HistoryEstratest was first marketed in the United States in 1965 by Reid-Provident Laboratories, which as 100% of Reid-Rowell, Inc. stock was acquired by the Belgian pharmaceutical company Solvay in 1986. There has been some controversy surrounding the drug in recent years as to its status with the FDA. Solvay is currently sponsoring a clinical trial of Estratest in the United States to determine whether the product is superior to treatment with esterified estrogens tablets DosageEstratest is sold in tablet form, with either 1.25 mg estrogens/2.5 mg methyltestosterone or 0.625 mg estrogens/1.25 mg methyltestosterone available. SupplyEstratest is supplied by Solvay. References
|
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Estratest". A list of authors is available in Wikipedia. |